Revvity Inc. (NYSE:RVTY) Receives Consensus Recommendation of "Hold" from Analysts

Key Points

• Analysts have an average recommendation of Hold on Revvity from 13 covering firms (1 sell, 9 hold, 3 buy) with an average 1‑year price target of $109.36, though individual targets and ratings vary widely (Evercore $118, JPMorgan $96, Weiss downgraded to sell).
• Revvity beat quarterly expectations with $1.70 EPS vs. $1.55 est. and $772.1M revenue (up 5.9% YoY); shares opened at $86.79, market cap about $9.7B, P/E ~41.7 and a 52‑week range of $81.22–$118.30.

Shares of Revvity Inc. (NYSE:RVTY - Get Free Report) have been assigned an average recommendation of "Hold" from the thirteen analysts that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, nine have issued a hold recommendation and three have given a buy recommendation to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $109.3636.

A number of brokerages have recently commented on RVTY. Evercore increased their price objective on Revvity from $112.00 to $118.00 and gave the company an "outperform" rating in a report on Tuesday, February 3rd. Robert W. Baird lowered their price objective on Revvity from $129.00 to $125.00 and set an "outperform" rating on the stock in a report on Monday. Jefferies Financial Group increased their price objective on Revvity from $100.00 to $105.00 and gave the company a "hold" rating in a report on Monday, February 2nd. JPMorgan Chase & Co. lowered their price objective on Revvity from $105.00 to $96.00 and set a "neutral" rating on the stock in a report on Tuesday, March 31st. Finally, Weiss Ratings lowered Revvity from a "hold (c-)" rating to a "sell (d+)" rating in a report on Wednesday, March 18th.

Revvity Stock Performance

Shares of NYSE RVTY opened at $86.79 on Tuesday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.40 and a current ratio of 1.68. The firm has a market cap of $9.70 billion, a price-to-earnings ratio of 41.73, a P/E/G ratio of 1.85 and a beta of 1.05. The business's 50-day simple moving average is $90.39 and its 200-day simple moving average is $96.82. Revvity has a 52 week low of $81.22 and a 52 week high of $118.30.

Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings data on Monday, February 2nd. The company reported $1.70 EPS for the quarter, beating analysts' consensus estimates of $1.55 by $0.15. The business had revenue of $772.06 million for the quarter, compared to analyst estimates of $759.81 million. Revvity had a return on equity of 7.92% and a net margin of 8.45%.The firm's revenue for the quarter was up 5.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.42 EPS. As a group, equities research analysts expect that Revvity will post 5.39 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Friday, July 17th will be issued a $0.07 dividend. The ex-dividend date of this dividend is Friday, July 17th. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. Revvity's dividend payout ratio (DPR) is 13.46%.

Institutional Trading of Revvity

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Ascentis Independent Advisors acquired a new stake in Revvity in the 1st quarter valued at approximately $29,000. CYBER HORNET ETFs LLC acquired a new stake in Revvity in the 2nd quarter valued at approximately $32,000. Cromwell Holdings LLC grew its holdings in Revvity by 141.4% in the 4th quarter. Cromwell Holdings LLC now owns 338 shares of the company's stock valued at $33,000 after buying an additional 198 shares during the last quarter. MUFG Securities EMEA plc acquired a new stake in Revvity in the 2nd quarter valued at approximately $34,000. Finally, Headlands Technologies LLC acquired a new stake in Revvity in the 2nd quarter valued at approximately $49,000. Institutional investors and hedge funds own 86.65% of the company's stock.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.